1128 related articles for article (PubMed ID: 32680882)
21. Lysine 164 is critical for SARS-CoV-2 Nsp1 inhibition of host gene expression.
Shen Z; Zhang G; Yang Y; Li M; Yang S; Peng G
J Gen Virol; 2021 Jan; 102(1):. PubMed ID: 33151142
[TBL] [Abstract][Full Text] [Related]
22. Severe acute respiratory syndrome coronavirus nsp1 facilitates efficient propagation in cells through a specific translational shutoff of host mRNA.
Tanaka T; Kamitani W; DeDiego ML; Enjuanes L; Matsuura Y
J Virol; 2012 Oct; 86(20):11128-37. PubMed ID: 22855488
[TBL] [Abstract][Full Text] [Related]
23. Viral and cellular translation during SARS-CoV-2 infection.
Eriani G; Martin F
FEBS Open Bio; 2022 Sep; 12(9):1584-1601. PubMed ID: 35429230
[TBL] [Abstract][Full Text] [Related]
24. Targeting stem-loop 1 of the SARS-CoV-2 5' UTR to suppress viral translation and Nsp1 evasion.
Vora SM; Fontana P; Mao T; Leger V; Zhang Y; Fu TM; Lieberman J; Gehrke L; Shi M; Wang L; Iwasaki A; Wu H
Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35149555
[TBL] [Abstract][Full Text] [Related]
25. Molecular pharmacology of ciclesonide against SARS-CoV-2.
Kimura H; Kurusu H; Sada M; Kurai D; Murakami K; Kamitani W; Tomita H; Katayama K; Ryo A
J Allergy Clin Immunol; 2020 Aug; 146(2):330-331. PubMed ID: 32593491
[No Abstract] [Full Text] [Related]
26. The Endonucleolytic RNA Cleavage Function of nsp1 of Middle East Respiratory Syndrome Coronavirus Promotes the Production of Infectious Virus Particles in Specific Human Cell Lines.
Nakagawa K; Narayanan K; Wada M; Popov VL; Cajimat M; Baric RS; Makino S
J Virol; 2018 Nov; 92(21):. PubMed ID: 30111568
[TBL] [Abstract][Full Text] [Related]
27. An Evolutionarily Conserved Strategy for Ribosome Binding and Host Translation Inhibition by β-coronavirus Non-structural Protein 1.
Maurina SF; O'Sullivan JP; Sharma G; Pineda Rodriguez DC; MacFadden A; Cendali F; Henen MA; Vögeli B; Kieft JS; Glasgow A; Steckelberg AL
J Mol Biol; 2023 Oct; 435(20):168259. PubMed ID: 37660941
[TBL] [Abstract][Full Text] [Related]
28. I(nsp1)ecting SARS-CoV-2-ribosome interactions.
Simeoni M; Cavinato T; Rodriguez D; Gatfield D
Commun Biol; 2021 Jun; 4(1):715. PubMed ID: 34112887
[TBL] [Abstract][Full Text] [Related]
29. In vitro reconstitution of SARS-CoV-2 Nsp1-induced mRNA cleavage reveals the key roles of the N-terminal domain of Nsp1 and the RRM domain of eIF3g.
Abaeva IS; Arhab Y; Miścicka A; Hellen CUT; Pestova TV
Genes Dev; 2023 Sep; 37(17-18):844-860. PubMed ID: 37821106
[TBL] [Abstract][Full Text] [Related]
30. What about the original antigenic sin of the humans versus SARS-CoV-2?
Roncati L; Palmieri B
Med Hypotheses; 2020 Sep; 142():109824. PubMed ID: 32408068
[No Abstract] [Full Text] [Related]
31. Drug targeting Nsp1-ribosomal complex shows antiviral activity against SARS-CoV-2.
Afsar M; Narayan R; Akhtar MN; Das D; Rahil H; Nagaraj SK; Eswarappa SM; Tripathi S; Hussain T
Elife; 2022 Mar; 11():. PubMed ID: 35323109
[TBL] [Abstract][Full Text] [Related]
32. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.
Kim CH
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730
[TBL] [Abstract][Full Text] [Related]
33. Repurposing of FDA-Approved Toremifene to Treat COVID-19 by Blocking the Spike Glycoprotein and NSP14 of SARS-CoV-2.
Martin WR; Cheng F
J Proteome Res; 2020 Nov; 19(11):4670-4677. PubMed ID: 32907334
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
[TBL] [Abstract][Full Text] [Related]
35. Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy.
Goyal B; Goyal D
ACS Comb Sci; 2020 Jun; 22(6):297-305. PubMed ID: 32402186
[TBL] [Abstract][Full Text] [Related]
36. Structural insights into the activity regulation of full-length non-structural protein 1 from SARS-CoV-2.
Wang Y; Kirkpatrick J; Lage SZ; Carlomagno T
Structure; 2023 Feb; 31(2):128-137.e5. PubMed ID: 36610391
[TBL] [Abstract][Full Text] [Related]
37. Nsp1 of SARS-CoV-2 stimulates host translation termination.
Shuvalov A; Shuvalova E; Biziaev N; Sokolova E; Evmenov K; Pustogarov N; Arnautova A; Matrosova V; Egorova T; Alkalaeva E
RNA Biol; 2021 Nov; 18(sup2):804-817. PubMed ID: 34793288
[TBL] [Abstract][Full Text] [Related]
38. Extended ensemble simulations of a SARS-CoV-2 nsp1-5'-UTR complex.
Sakuraba S; Xie Q; Kasahara K; Iwakiri J; Kono H
PLoS Comput Biol; 2022 Jan; 18(1):e1009804. PubMed ID: 35045069
[TBL] [Abstract][Full Text] [Related]
39. Molecular Binding Mechanism and Pharmacology Comparative Analysis of Noscapine for Repurposing against SARS-CoV-2 Protease.
Kumar N; Sood D; van der Spek PJ; Sharma HS; Chandra R
J Proteome Res; 2020 Nov; 19(11):4678-4689. PubMed ID: 32786685
[TBL] [Abstract][Full Text] [Related]
40. Revealing druggable cryptic pockets in the Nsp1 of SARS-CoV-2 and other β-coronaviruses by simulations and crystallography.
Borsatto A; Akkad O; Galdadas I; Ma S; Damfo S; Haider S; Kozielski F; Estarellas C; Gervasio FL
Elife; 2022 Nov; 11():. PubMed ID: 36412088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
